 |
|
|
|
|
| |
 |
|
|
| |
Boston Millennia Partners’ portfolio reflects Millennia’s commitment towards building enduring, large-scale businesses that have the potential to provide superior financial returns to our investors. Millennia’s portfolio is comprised of a diversified group of firms each positioned with the potential to become leaders in their respective market segments. We invite you to use the links below to learn more about each of those portfolio companies. |
|
| |
|
|
| |
| |
|
| |
|
|
46040 Center Oak Plaza
Suite 100
Sterling , VA 20166
Phone: 703-421-6720
Fax: 703-421-6708
|
|
| |
| |
Galt Associates, Inc. is a pharmacovigilance support company, specializing in the delivery of web-based compliance and analysis solutions for the pharmaceutical industry. This helps pharmaceutical companies manage drug safety data and accelerate the drug approval process for faster-time-to peak sales for approved drugs.
The company has both software and services arms. The product suite is made up of industry leading solutions including some of the industry’s most innovative web-based applications: DrugSafety.com, dsNavigator, dsGateway, dsAnalysis, and Informatics-Online. More than an Internet software company, Galt builds products which spring from their comprehensive knowledge of the pharmaceutical industry, as well as their extensive research and consulting experience in safety analysis, disease modeling, outcomes research, employer-based productivity research, and health economics.
|
|
| |
|
| Millennia Team |
Rob Jevon
|
|
| Investment Date |
July 2001 |
|
| Visit the Website |
http://www.galt-assoc.com/ |
|
| Case Study |
Acquired by the Cerner Corporation (NASDAQ: CERN) in July, 2006, Galt Associates is an example of Boston Millennia Partners’ expertise in the healthcare information technology sector and their commitment to help dedicated management teams grow their companies over the long run. Founded in 1994, Galt Associates is recognized as an international leader in the drug safety and risk management solutions industries. Boston Millennia Partners began its relationship with Galt in 2001 as the lead investor in its original Series A financing. Represented at the board level by Partner Robert Jevon, Millennia worked with Galt’s founders to grow the business from a niche software company in the drug safety market to a complete pharmacovigilence solutions provider. During Millennia’s tenure as investors in Galt, the company developed new products to complement its initial offering and in doing so created a comprehensive solutions suite to fit the needs of life science companies of all sizes. In their five years working with the company, Millennia also helped Galt extensively expand its consulting services to complement its software solutions. At the time of sale, Galt counted 16 of the world’s 20 largest life science companies as customers and had tripled its sales since Millennia made its initial investment. Having the prescience to invest in the pharmacovigilence space ahead of the FDA’s increasing of post-clinical regulatory requirements, Cerner’s all cash acquisition of the company provided Millennia with a strong return for the firm’s Limited Partners.
|
|
| Related News |
Boston, MA – July 6, 2006
Cerner Corp. Acquires Galt Associates
Kansas City, MO - June 14, 2006
Cerner to Acquire Galt Associates, Leader in Drug Safety and Risk Management Solutions
Sterling, Virginia, May 2, 2006
Galt Supports SNOMED “Problem List”
Irvine, CA - February 8, 2006
DataLabs to Integrate Galt's dsNavigator Coding Product with Their Hybrid Clinical Data
Sterling, Virginia - June 27, 2005
Galt Releases dsNavigator 3.1 at DIA 41st Annual Meeting
Irvine, CA - June 27, 2005
Relsys and Galt Announce Argus SafetyTM and dsNavigatorTM Product Integration Initiative
San Ramon, CA — June 27, 2005
Nextrials and Galt Associates Form Partnership to Expedite Data Exchange and Track Adverse Events and Safety Trends During Clinical Trials
Sterling, Virginia - June 24, 2005
Galt to unveil Halo 2.0 at DIA 41st Annual Meeting
Sterling, VA and Uppsala, Sweden - January 5, 2005
Galt and UMC partner to offer the UMC's Vigibase core data set through Galt's Halo drug safety and research platform
Sterling, VA - July 19, 2004
Galt Names Y. Renee Lewis Chief Executive Officer
Sterling, VA - October 14, 2003
Deloitte Names Galt to Virginia’s "Technology Fast 50" and North America’s "Technology Fast 500" for Second Year in a Row
|
|
|
|
|
|
|
|
|
|
